Literature DB >> 8410878

Intraarticular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review.

J G Peyron1.   

Abstract

Viscosupplementation (restoring the rheological properties of a tissue matrix) by injection of hyaluronan into the joints has been in use for 2 decades, mostly for osteoarthritis (OA) of the knee, using doses of 20-25 mg of hyaluronan of 500,000 to 2,500,000 M(r), in sequences of 2 to 10 weekly injections. Pain relief appears in a few days, progresses over a few weeks, and often lasts several months. Some data suggest the benefit can last 6 months to one year. Tolerance is universally reported as very good. Those responding to hyaluronan are 65-80%, compared to 30-35% responding to control. Compared to local steroid injections, the effect of hyaluronan appears significantly more lasting. More highly viscoelastic preparations of hyaluronan can be expected to make this therapy even more attractive.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8410878

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  13 in total

1.  Hyaluronan production in human rheumatoid fibroblastic synovial lining cells is increased by interleukin 1 beta but inhibited by transforming growth factor beta 1.

Authors:  M Kawakami; K Suzuki; Y Matsuki; T Ishizuka; T Hidaka; T Konishi; M Matsumoto; K Kataharada; H Nakamura
Journal:  Ann Rheum Dis       Date:  1998-10       Impact factor: 19.103

Review 2.  Anatomy and pathophysiology of the sacroiliac joint.

Authors:  O Calvillo; I Skaribas; J Turnipseed
Journal:  Curr Rev Pain       Date:  2000

Review 3.  Viscosupplementation treatment of arthritis pain.

Authors:  Michael Benke; Benjamin Shaffer
Journal:  Curr Pain Headache Rep       Date:  2009-12

4.  Hylan G-F 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment.

Authors:  D Cubukçu; F Ardiç; N Karabulut; O Topuz
Journal:  Clin Rheumatol       Date:  2004-12-14       Impact factor: 2.980

5.  Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation.

Authors:  M A Dentener; J H J Vernooy; S Hendriks; E F M Wouters
Journal:  Thorax       Date:  2005-02       Impact factor: 9.139

Review 6.  Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis.

Authors:  Egemen Ayhan; Hayrettin Kesmezacar; Isik Akgun
Journal:  World J Orthop       Date:  2014-07-18

Review 7.  Osteoarthritis. A continuing challenge.

Authors:  K E Sack
Journal:  West J Med       Date:  1995-12

Review 8.  Viscosupplementation for the treatment of osteoarthritis of the knee.

Authors:  N Bellamy; J Campbell; V Robinson; T Gee; R Bourne; G Wells
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

9.  Effect of Combined Leukocyte-Poor Platelet-Rich Plasma and Hyaluronic Acid on Bone Marrow-Derived Mesenchymal Stem Cell and Chondrocyte Metabolism.

Authors:  Alexander M Satin; Jolanta B Norelli; Nicholas A Sgaglione; Daniel A Grande
Journal:  Cartilage       Date:  2019-07-07       Impact factor: 3.117

10.  Intra-articular injection of a nutritive mixture solution protects articular cartilage from osteoarthritic progression induced by anterior cruciate ligament transection in mature rabbits: a randomized controlled trial.

Authors:  Yoo-Sin Park; Si-Woong Lim; Il-Hoon Lee; Tae-Jin Lee; Jong-Sung Kim; Jin Soo Han
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.